Reminder – COVID TESTING AND ISOLATION GUIDANCE FOR HEALTH AND SOCIAL CARE WORKERS – Still active since May 2022
Still Active in 2023
Read MoreCategory: COVID 19
COVID-19 AUTUMN/WINTER BOOSTER VACCINATION PROGRAMME 2023
The COVID-19 vaccination programme will therefore commence in Northern Ireland on 18 September 2023 to ensure that those most at risk from winterillness i.e. people in care homes, the clinically vulnerable, everyone aged 65 and...
Read MoreRecognition, diagnosis, and management of long COVID
This Guidelines summary of Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study covers key recommendations to provide a rapid expert guide for GPs and clinical services in the recognition,...
Read MoreGPNI Clinical Update: Updates on The Post COVID Syndrome Service and The Condition Management Programme
The Post COVID Syndrome Service has recently been developed within each Trust in response to the needs of the post COVID population while the Condition Management Programme continues to develop to meet the changing needs of...
Read MorePanoramic Clinical Trial
You may be aware of a recent announcement by the UK Governmentabout the use of new antiviral treatments across the four UK nations within the Panoramic Clinical Trial to treat certain patient cohorts in thecommunity with...
Read MoreUPDATED POLICY FOR MANAGEMENT OF SELF-ISOLATION OF CLOSE CONTACTS OF COVID-19 CASES – ADDITIONAL SAFEGUARDS FOR HEALTH AND SOCIAL CARE STAFF -HSS(MD)91/2021
The purpose of this letter is to: 1. Provide updated guidance on the management of health and social care workers identified as close contacts of COVID-19. 2. Provide updated guidance on isolation requirements for health and...
Read MoreJCVI UPDATE ON ADVICE FOR COVID-19 VACCINATION OF CHILDREN AND YOUNG PEOPLE (Primary vaccination of 5-11 year olds & Booster Vaccination in persons aged 12 to 17 years)
JCVI has now issued updated advice in relation to COVID-19 vaccination of children and young people. The full JCVI statement can be found here...
Read MoreINFORMATION ABOUT COVID-19 TREATMENTS – NEUTRALISING MONOCLONAL ANTIBODIES (nMAB) OR ANTIVIRALS FOR NON-HOSPITALISED PATIENTS WITH COVID-19.
The highest risk cohorts are as defined in the Interim Clinical Policy developed by the Rapid C-19 policy expert group. A list of the cohort categories is attached to this letter for ease of reference. Access to these treatments...
Read MoreInfection Prevention and Control for Seasonal Respiratory Infections in Health and Care settings (including SARS-CoV-2 for) Winter 2021/2022
Infection Prevention and Control for Seasonal Respiratory Infections in Health and Care settings (including SARS-CoV-2 for) Winter 2021/2022 Infection Prevention and Control for Seasonal Respiratory Infections in Health and Care...
Read MoreHSS(MD) 78/2021 – IMMEDIATE ACTIONS IN RESPONSE TO NEW VARIANT (B.1.1.529) SARS-COV-2 – Omicron
HSS(MD) 78/2021 - IMMEDIATE ACTIONS IN RESPONSE TO NEW VARIANT (B.1.1.529) SARS-COV-2 - Omicron The variant has a number of mutations in key locations of the genome which suggest it may be highly transmissible and may be able to...
Read More
COVID-19 vaccination in children and young people aged 16 to 17 years: JCVI statement, November 2021 – GOV.UK
The Joint Committee on Vaccination and Immunisation (JCVI) has previously advised: 2 doses of the Pfizer-BioNTech COVID-19 vaccine in children and young people aged 16 to 17 years with an underlying health condition that places...
Read MoreNI COVID-19 Spring Booster Programme
NI COVID-19 Booster & Flu Vaccination Programme & Vaccinator Training Resources Introduction & Key Links Welcome to the GPNI COVID-19 Booster & Flu Vaccination Programme hub – if you have feedback or...
Read MoreGPNI Clinical Update: Long Covid
We will be joined by members of the Long Covid working group to update us on the latest clinical evidence around Long Covid and emerging pathways, services and resources within the HSC to help patients. Give feedback and...
Read MoreBooster info added to Greenbook
Booster info added to Greenbook Booster information on Covid vaccination added to the Greenbook Page 21 sets out the criteria for a third primary dose of COVID-19 vaccine....
Read MorePHA – COVID-19 Vaccination & Thrombosis – NI Update 22/4/21 – Dr Claire Corrigan & Dr Gary Benson
Give Feedback & Gain a Certificate for CPD This is a professional education video by the Public Health Agency and Consultant Haematologists at the Belfast Trust for GPs. It provides background information and advice on the...
Read MoreHSS(MD) 29/2021 – COVID-19 THERAPEUTIC ALERT – INHALED BUDESONIDE FOR ADULTS (50 YEARS AND OVER) WITH COVID-19
HSS(MD) 29/2021 - COVID-19 THERAPEUTIC ALERT - INHALED BUDESONIDE FOR ADULTS (50 YEARS AND OVER) WITH COVID-19 Recommendation Inhaled budesonide is not currently being recommended as standard of care but can be considered...
Read MoreNorthern Ireland COVID-19 Vaccination Programme
The Department of Health Covid Vaccination Dashboard NI Covid-19 Vaccinations Dashboard Link for feedback & CPD Certificate The Green Book : Chapter 14a The coronavirus (COVID-19) vaccines The dosage and schedule for the UK...
Read MoreHSS(MD)26/2021 – VACCINATION PROTOCOL FOR COVID-19 VACCINE ASTRAZENECA
Attached is a vaccination protocol for COVID – 19 AstraZeneca from Dr Michael McBride Version 1.0 Covid-19 Vaccination Protocol for AstraZenica Vaccine (March 2021) File size: 690.02 KB Updated: 30-03-2021 Download Preview...
Read MoreProtoocol for vaccination of patients where they live using AZ Covid 19 Vaccine
Suitability for COVID-19 vaccination based on prior allergy or current dietary practices – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice...
Read MoreCOVID-19 THERAPEUTIC ALERT – ANTIMICROBIALS (AZITHROMYCIN AND DOXYCYCLINE) NOT BENEFICIAL IN THE MANAGEMENT OF COVID-19 – (SARS-CoV-2) POSITIVE PATIENTS
Azithromycin should NOT be used in the management of confirmed or suspected COVID-19 infection either within primary care or in hospitalised patients, unless there are additional indications for which its use remains appropriate...
Read More
